GLAXFGSK
GSK plc
Healthcare · Pharmaceutical Preparations · LONDON · CIK 0001131399
Ownership
Who holds GSK plc — from fund N-PORT and institutional 13F filings · N-PORT 2026Q1 · 13F 2026-03-31
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| Dodge & Cox Stock Fund DODGX · Dodge & Cox Funds | 2.07% | $2.37B |
| Dodge & Cox International Stock Fund DODFX · Dodge & Cox Funds | 3.35% | $2.05B |
| Strategic Advisers Fidelity U.S. Total Stock Fund FCTDX · Fidelity Rutland Square Trust II | 0.21% | $459.57M |
| Dodge & Cox Global Stock Fund DODWX · Dodge & Cox Funds | 2.55% | $305.79M |
| Bridge Builder International Equity Fund BBIEX · Bridge Builder Trust | 1.24% | $291.65M |
Superinvestors in GSK plc
3.7%
0.4%
Share of each manager's reported 13F portfolio.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
15 years of GSK plc's financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free